103 related articles for article (PubMed ID: 11193855)
1. Imaging tumors in humans with Tc-99m-VIP.
Thakur ML; Marcus CS; Saeed S; Pallela V; Minami C; Diggles L; Pham HL; Ahdoot R; Kalinowski EA; Moody T
Ann N Y Acad Sci; 2000; 921():37-44. PubMed ID: 11193855
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog.
Thakur ML; Aruva MR; Gariepy J; Acton P; Rattan S; Prasad S; Wickstrom E; Alavi A
J Nucl Med; 2004 Aug; 45(8):1381-9. PubMed ID: 15299065
[TBL] [Abstract][Full Text] [Related]
3. 99mTc labeled VIP analog: evaluation for imaging colorectal cancer.
Rao PS; Thakur ML; Pallela V; Patti R; Reddy K; Li H; Sharma S; Pham HL; Diggles L; Minami C; Marcus CS
Nucl Med Biol; 2001 May; 28(4):445-50. PubMed ID: 11395318
[TBL] [Abstract][Full Text] [Related]
4. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
5. Primary osteogenic sarcoma of breast detected on Tc-99m MIBI scintigraphy and Tc-99m MDP skeletal scintigraphy.
Yang JG; Li CL; Hao RR; Zou LF
Ann Nucl Med; 2008 Jan; 22(1):79-82. PubMed ID: 18250991
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Tc-99m THY and Tc-99m MIBI scans for diagnosis of breast lesions.
Gutfilen B; Fonseca LM
J Exp Clin Cancer Res; 2001 Sep; 20(3):385-91. PubMed ID: 11718219
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-labeled vasoactive intestinal peptide analog for rapid localization of tumors in humans.
Thakur ML; Marcus CS; Saeed S; Pallela V; Minami C; Diggles L; Le Pham H; Ahdoot R; Kalinowski EA
J Nucl Med; 2000 Jan; 41(1):107-10. PubMed ID: 10647612
[TBL] [Abstract][Full Text] [Related]
8. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.
Gorlick R; Liao AC; Antonescu C; Huvos AG; Healey JH; Sowers R; Daras M; Calleja E; Wexler LH; Panicek D; Meyers PA; Yeh SD; Larson SM
Clin Cancer Res; 2001 Oct; 7(10):3065-70. PubMed ID: 11595696
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
11. Tc-99m sestamibi scintimammography for the diagnosis of breast cancer: meta-analysis and meta-regression.
Xu HB; Li L; Xu Q
Nucl Med Commun; 2011 Nov; 32(11):980-8. PubMed ID: 21956488
[TBL] [Abstract][Full Text] [Related]
12. Comparison of double phase Tc-99m MIBI and Tc-99m tetrofosmin scintimammography for characterization of breast lesions: Visual and quantitative analyses.
Kim IJ; Kim SJ; Kim YK
Neoplasma; 2008; 55(6):526-31. PubMed ID: 18999882
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of (99m)Tc-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with X-rays mammography, ultrasonography and magnetic resonance imaging.
Ozülker T; Ozülker F; Ozpaçaci T; Bender O; Değirmenci H
Hell J Nucl Med; 2010; 13(2):144-9. PubMed ID: 20808988
[TBL] [Abstract][Full Text] [Related]
14. Prescintigraphic morphine application for abdominal adenocarcinoma imaging, with technetium-99m methoxy isobutyl isonitrile.
Ferlitsch A; Steindl-Munda P; Haefner M; Peck-Radosavljevic M; Madl C; Pötzi R; Homoncik M; Weidekamm C; Granegger S; Sinzinger H
Hell J Nucl Med; 2007; 10(1):14-8. PubMed ID: 17450244
[TBL] [Abstract][Full Text] [Related]
15. Scintimammographic findings of phyllodes tumor of the breast in a double-phase study with Tc-99m (V)DMSA and Tc-99m MIBI: a case report.
Papantoniou V; Koutsikos J; Sotiropoulou M; Mainta E; Lazaris D; Tsiouris S; Zerva C
Jpn J Clin Oncol; 2004 Jul; 34(7):429-31. PubMed ID: 15342672
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-MIBI imaging of cutaneous AIDS-associated Kaposi's sarcoma.
Peer FI; Pui MH; Mosam A; Rae WI
Int J Dermatol; 2007 Feb; 46(2):166-71. PubMed ID: 17269969
[TBL] [Abstract][Full Text] [Related]
17. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
Moustafa H; Riad R; Omar W; Zaher A; Ebied E
Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
[TBL] [Abstract][Full Text] [Related]
19. Potential of (99m)Tc-MIBI for detecting bone marrow metastases.
Wakasugi S; Noguti A; Katuda T; Hashizume T; Hasegawa Y
J Nucl Med; 2002 May; 43(5):596-602. PubMed ID: 11994520
[TBL] [Abstract][Full Text] [Related]
20. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
